Cambrex, a small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, has named Tom Loewald as its chief executive officer and a member of the company’s board of directors, effective September 7, 2020. As previously announced, in the interim, the company will be led by an Office of the CEO comprised of Wayne Hewett, chairman of the board, Robert Green, executive vice president and chief financial officer, and Samantha Hanley, senior vi...